History of Antiphospholipid Antibody View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2017-06-10

AUTHORS

Michael D. Lockshin , E. Nigel Harris

ABSTRACT

If one adds molecular and biological science to clinical description, the history of antiphospholipid antibody (aPL) and antiphospholipid syndrome (APS) contains nine phases. We base this history on personal memory (primarily that of MDL) and on conversations with the early North American leaders, Samuel Rapaport, Lawrence Shulman, Sandor Shapiro, Donato Alarcon-Segovia, and Carl Alving; others have seen the history differently. The nine phases emphasize mechanistic studies as well as clinical ones. Although the North American view necessarily has a New World bias, we do not wish to understate the important contributions from Europe, Asia, South Africa, Australia, and Central and South America—it’s just that we have less personal experience with them. This history omits many investigators, papers, and contributions. For those omissions I (MDL) apologize. More... »

PAGES

3-11

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-319-55442-6_1

DOI

http://dx.doi.org/10.1007/978-3-319-55442-6_1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1085964127


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/21", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "History and Archaeology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Historical Studies", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Hospital for Special Surgery, Weill Cornell Medicine, Department of Rheumatology, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.5386.8", 
          "name": [
            "Hospital for Special Surgery, Weill Cornell Medicine, Department of Rheumatology, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lockshin", 
        "givenName": "Michael D.", 
        "id": "sg:person.01215046705.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215046705.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The University of the West Indies, Mona, Kingston, Jamaica", 
          "id": "http://www.grid.ac/institutes/grid.461576.7", 
          "name": [
            "The University of the West Indies, Mona, Kingston, Jamaica"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Harris", 
        "givenName": "E. Nigel", 
        "id": "sg:person.011340100772.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011340100772.08"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2017-06-10", 
    "datePublishedReg": "2017-06-10", 
    "description": "If one adds molecular and biological science to clinical description, the history of antiphospholipid antibody (aPL) and antiphospholipid syndrome (APS) contains nine phases. We base this history on personal memory (primarily that of MDL) and on conversations with the early North American leaders, Samuel Rapaport, Lawrence Shulman, Sandor Shapiro, Donato Alarcon-Segovia, and Carl Alving; others have seen the history differently. The nine phases emphasize mechanistic studies as well as clinical ones. Although the North American view necessarily has a New World bias, we do not wish to understate the important contributions from Europe, Asia, South Africa, Australia, and Central and South America\u2014it\u2019s just that we have less personal experience with them. This history omits many investigators, papers, and contributions. For those omissions I (MDL) apologize.", 
    "editor": [
      {
        "familyName": "Erkan", 
        "givenName": "Doruk", 
        "type": "Person"
      }, 
      {
        "familyName": "Lockshin", 
        "givenName": "Michael D.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-319-55442-6_1", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-319-55440-2", 
        "978-3-319-55442-6"
      ], 
      "name": "Antiphospholipid Syndrome", 
      "type": "Book"
    }, 
    "keywords": [
      "North American leaders", 
      "North American view", 
      "Alarcon-Segovia", 
      "American leaders", 
      "American view", 
      "personal memories", 
      "history", 
      "South Africa", 
      "South America", 
      "personal experience", 
      "important contribution", 
      "apologize", 
      "Alving", 
      "Europe", 
      "Asia", 
      "America", 
      "leaders", 
      "Africa", 
      "Central", 
      "Rapaport", 
      "Shulman", 
      "conversation", 
      "biological sciences", 
      "memory", 
      "clinical description", 
      "Shapiro", 
      "science", 
      "contribution", 
      "Australia", 
      "view", 
      "experience", 
      "one", 
      "description", 
      "paper", 
      "phase", 
      "study", 
      "bias", 
      "clinical one", 
      "investigators", 
      "syndrome", 
      "antiphospholipid antibodies", 
      "antiphospholipid syndrome", 
      "mechanistic studies", 
      "antibodies", 
      "early North American leaders", 
      "Samuel Rapaport", 
      "Lawrence Shulman", 
      "Sandor Shapiro", 
      "Donato Alarcon-Segovia", 
      "Carl Alving", 
      "New World bias", 
      "World bias", 
      "omissions I (MDL) apologize", 
      "I (MDL) apologize"
    ], 
    "name": "History of Antiphospholipid Antibody", 
    "pagination": "3-11", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1085964127"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-319-55442-6_1"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-319-55442-6_1", 
      "https://app.dimensions.ai/details/publication/pub.1085964127"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2021-11-01T18:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/chapter/chapter_153.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-319-55442-6_1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-55442-6_1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-55442-6_1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-55442-6_1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-55442-6_1'


 

This table displays all metadata directly associated to this object as RDF triples.

129 TRIPLES      23 PREDICATES      79 URIs      72 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-319-55442-6_1 schema:about anzsrc-for:21
2 anzsrc-for:2103
3 schema:author N3598f9d33c3945f7a7bedd9980ec7ae0
4 schema:datePublished 2017-06-10
5 schema:datePublishedReg 2017-06-10
6 schema:description If one adds molecular and biological science to clinical description, the history of antiphospholipid antibody (aPL) and antiphospholipid syndrome (APS) contains nine phases. We base this history on personal memory (primarily that of MDL) and on conversations with the early North American leaders, Samuel Rapaport, Lawrence Shulman, Sandor Shapiro, Donato Alarcon-Segovia, and Carl Alving; others have seen the history differently. The nine phases emphasize mechanistic studies as well as clinical ones. Although the North American view necessarily has a New World bias, we do not wish to understate the important contributions from Europe, Asia, South Africa, Australia, and Central and South America—it’s just that we have less personal experience with them. This history omits many investigators, papers, and contributions. For those omissions I (MDL) apologize.
7 schema:editor N6ca94e7587dc418791ca3b655d8faec0
8 schema:genre chapter
9 schema:inLanguage en
10 schema:isAccessibleForFree false
11 schema:isPartOf N6de273f1c69d4110be0bd6f8b98493bf
12 schema:keywords Africa
13 Alarcon-Segovia
14 Alving
15 America
16 American leaders
17 American view
18 Asia
19 Australia
20 Carl Alving
21 Central
22 Donato Alarcon-Segovia
23 Europe
24 I (MDL) apologize
25 Lawrence Shulman
26 New World bias
27 North American leaders
28 North American view
29 Rapaport
30 Samuel Rapaport
31 Sandor Shapiro
32 Shapiro
33 Shulman
34 South Africa
35 South America
36 World bias
37 antibodies
38 antiphospholipid antibodies
39 antiphospholipid syndrome
40 apologize
41 bias
42 biological sciences
43 clinical description
44 clinical one
45 contribution
46 conversation
47 description
48 early North American leaders
49 experience
50 history
51 important contribution
52 investigators
53 leaders
54 mechanistic studies
55 memory
56 omissions I (MDL) apologize
57 one
58 paper
59 personal experience
60 personal memories
61 phase
62 science
63 study
64 syndrome
65 view
66 schema:name History of Antiphospholipid Antibody
67 schema:pagination 3-11
68 schema:productId N448bf1d919c44e1d8b4f78cd7161e5b2
69 Nc7a040268ef3479abaa3e10e21656c54
70 schema:publisher N04ccead10cfe4d7a8a82fd1ba20019bf
71 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085964127
72 https://doi.org/10.1007/978-3-319-55442-6_1
73 schema:sdDatePublished 2021-11-01T18:48
74 schema:sdLicense https://scigraph.springernature.com/explorer/license/
75 schema:sdPublisher N24f2d5929cfa4474aa7592721e019004
76 schema:url https://doi.org/10.1007/978-3-319-55442-6_1
77 sgo:license sg:explorer/license/
78 sgo:sdDataset chapters
79 rdf:type schema:Chapter
80 N04ccead10cfe4d7a8a82fd1ba20019bf schema:name Springer Nature
81 rdf:type schema:Organisation
82 N24f2d5929cfa4474aa7592721e019004 schema:name Springer Nature - SN SciGraph project
83 rdf:type schema:Organization
84 N3598f9d33c3945f7a7bedd9980ec7ae0 rdf:first sg:person.01215046705.41
85 rdf:rest Nef83d93a230449d1bc82c0fd8feec4af
86 N448bf1d919c44e1d8b4f78cd7161e5b2 schema:name doi
87 schema:value 10.1007/978-3-319-55442-6_1
88 rdf:type schema:PropertyValue
89 N6ca94e7587dc418791ca3b655d8faec0 rdf:first Nadd1fbdd3e0742a7a98b18f852503b34
90 rdf:rest Naad6680fe51a4b9783ea5d8eee9dc1eb
91 N6de273f1c69d4110be0bd6f8b98493bf schema:isbn 978-3-319-55440-2
92 978-3-319-55442-6
93 schema:name Antiphospholipid Syndrome
94 rdf:type schema:Book
95 Naad6680fe51a4b9783ea5d8eee9dc1eb rdf:first Ndc34162b283a411ca24bce5f2749dbc0
96 rdf:rest rdf:nil
97 Nadd1fbdd3e0742a7a98b18f852503b34 schema:familyName Erkan
98 schema:givenName Doruk
99 rdf:type schema:Person
100 Nc7a040268ef3479abaa3e10e21656c54 schema:name dimensions_id
101 schema:value pub.1085964127
102 rdf:type schema:PropertyValue
103 Ndc34162b283a411ca24bce5f2749dbc0 schema:familyName Lockshin
104 schema:givenName Michael D.
105 rdf:type schema:Person
106 Nef83d93a230449d1bc82c0fd8feec4af rdf:first sg:person.011340100772.08
107 rdf:rest rdf:nil
108 anzsrc-for:21 schema:inDefinedTermSet anzsrc-for:
109 schema:name History and Archaeology
110 rdf:type schema:DefinedTerm
111 anzsrc-for:2103 schema:inDefinedTermSet anzsrc-for:
112 schema:name Historical Studies
113 rdf:type schema:DefinedTerm
114 sg:person.011340100772.08 schema:affiliation grid-institutes:grid.461576.7
115 schema:familyName Harris
116 schema:givenName E. Nigel
117 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011340100772.08
118 rdf:type schema:Person
119 sg:person.01215046705.41 schema:affiliation grid-institutes:grid.5386.8
120 schema:familyName Lockshin
121 schema:givenName Michael D.
122 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215046705.41
123 rdf:type schema:Person
124 grid-institutes:grid.461576.7 schema:alternateName The University of the West Indies, Mona, Kingston, Jamaica
125 schema:name The University of the West Indies, Mona, Kingston, Jamaica
126 rdf:type schema:Organization
127 grid-institutes:grid.5386.8 schema:alternateName Hospital for Special Surgery, Weill Cornell Medicine, Department of Rheumatology, New York, NY, USA
128 schema:name Hospital for Special Surgery, Weill Cornell Medicine, Department of Rheumatology, New York, NY, USA
129 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...